Autres langues Cuorips Inc.

Actions

Marché Fermé - Japan Exchange 08:30:00 30/09/2026			Varia. 5j.	Varia. 1 janv.
6 640,00 ^JPY	+17,73%		+12,73%	+10,12%

06/03	Japon: premier traitement par cellules souches contre Parkinson approuvé	AW
20/02	Un panel japonais approuve les premières thérapies à base de cellules iPS pour une mise sur le marché conditionnelle	MT

28/09	Cuorips Inc. announced that it has received ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.
11/09	Cuorips Inc. announced that it expects to receive ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.
20/02	Japan Panel Clears First iPS Cell Therapies for Conditional Sale
19/02	UPDATE2: Japan gov't panel approves 2 iPS-derived drugs in global first
19/02	Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's
19/02	UPDATE1: Japan gov't panel approves 2 iPS-derived drugs in global first
19/02	Japan government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's, newspaper says
19/02	Japan gov't panel approves 2 iPS-derived drugs in global first
04/02	Takeda, Kyoto University to End Decade-Long iPS Research Tie-Up
23/09/24	Cuorips Inc.(TSE:4894) added to S&P Global BMI Index
23/12/23	Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.
24/09/23	Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023.
27/06/23	Cuorips Inc. has completed an IPO in the amount of Â¥3.432 billion.